ASTROTECH CORPORATION Announces Advancement in Detection of Lung Infections

November 22, 2022

https://www.globenewswire.com/news-release/2022/11/22/2561109/0/en/ASTROTECH-CORPORATION-Announces-Advancement-in-Detection-of-Lung-Infections.html

Austin, Texas, Nov. 22, 2022 (GLOBE NEWSWIRE) —  – Astrotech Corporation (Nasdaq:ASTC) (the “Company” or “Astrotech”) subsidiary, BreathTech Corporation (“BreathTech”), announced today that, based on analysis of data from testing of breath samples procured during our library development, the BreathTest-1000TM lung disease screening instrument can clearly distinguish between infected and healthy breath samples. The BreathTest-1000 is a breath analysis tool designed to screen for volatile organic compound metabolites found in a person’s breath that could indicate they may have a bacterial or viral infection.

Read more at globenewswire.com

Related news for (ASTC)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.